Guggenheim Begins Coverage on Unicycive Therapeutics (NASDAQ:UNCY)
Investment analysts at Guggenheim assumed coverage on shares of Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report) in a research note issued on Monday, Marketbeat reports. The brokerage set a “buy” rating and a $6.00 price target on the stock. Separately, HC Wainwright restated a “buy” rating and issued a $7.50 price target on shares of […]
Investment analysts at Guggenheim assumed coverage on shares of Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report) in a research note issued on Monday, Marketbeat reports. The brokerage set a “buy” rating and a $6.00 price target on the stock. Separately, HC Wainwright restated a “buy” rating and issued a $7.50 price target on shares of […]
